Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global consensus study published today in The Lancet.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
